Kewaunee agrees to acquire Nycom for $55 million, including $5 million in stock
On November 2, 2026, Kewaunee Scientific agreed to acquire Nycom, Inc., a laboratory design, distribution and installation business, for a base purchase price of $55 million, subject to adjustments tied to Nycom's adjusted EBITDA and other items. The deal is funded with cash, debt expected from PNC Bank, a $20 million subordinated seller note and $5 million of Kewaunee common stock, and it can be terminated if closing does not occur by March 31, 2027, so it adds debt and share issuance that shareholders will weigh against the expected benefits.
Key points
- Base purchase price of $55 million, with $30 million paid in cash at closing, including $1 million held in escrow
- $20 million subordinated seller note and $5 million of common stock issued to the seller, with a 12-month lock-up
- Debt financing expected from PNC Bank, National Association, to help fund the cash portion
- Outside date of March 31, 2027; expected to close in the fourth quarter of fiscal 2027
The filing
Written by AI on Nov 9, 2026, 8:51 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 02, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.